| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Alison Christy
|
|
|
|
22 |
5 |
p. 380
|
article
|
| 2 |
An old hypersomnia
|
Lees, Andrew J
|
|
|
22 |
5 |
p. 380
|
article
|
| 3 |
Application of diagnostic criteria for optic neuritis
|
Du, Yi
|
|
|
22 |
5 |
p. 375
|
article
|
| 4 |
Application of diagnostic criteria for optic neuritis
|
Gingele, Stefan
|
|
|
22 |
5 |
p. 375-376
|
article
|
| 5 |
Application of diagnostic criteria for optic neuritis – Authors' reply
|
Petzold, Axel
|
|
|
22 |
5 |
p. 376-377
|
article
|
| 6 |
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study
|
Siderowf, Andrew
|
|
|
22 |
5 |
p. 407-417
|
article
|
| 7 |
Chronic effects of inflammation on tauopathies
|
Langworth-Green, Connor
|
|
|
22 |
5 |
p. 430-442
|
article
|
| 8 |
Chronic inflammation: a potential target in tauopathies
|
Ising, Christina
|
|
|
22 |
5 |
p. 371-373
|
article
|
| 9 |
Correction to Lancet Neurol 2023; 22: 209–17
|
|
|
|
22 |
5 |
p. e7
|
article
|
| 10 |
Correction to Lancet Neurol 2023; 22: 303–11
|
|
|
|
22 |
5 |
p. e7
|
article
|
| 11 |
It's all in the detail
|
Gash, Danielle
|
|
|
22 |
5 |
p. 382
|
article
|
| 12 |
New therapies for autoimmune myasthenia gravis
|
Verschuuren, Jan
|
|
|
22 |
5 |
p. 368-369
|
article
|
| 13 |
Optimising epilepsy surgery
|
Duncan, John S
|
|
|
22 |
5 |
p. 373-374
|
article
|
| 14 |
Personalised virtual brain models in epilepsy
|
Jirsa, Viktor
|
|
|
22 |
5 |
p. 443-454
|
article
|
| 15 |
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
|
Bril, Vera
|
|
|
22 |
5 |
p. 383-394
|
article
|
| 16 |
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
|
Howard Jr, James F
|
|
|
22 |
5 |
p. 395-406
|
article
|
| 17 |
Sex, gender, and the cost of neurological disorders
|
The Lancet Neurology,
|
|
|
22 |
5 |
p. 367
|
article
|
| 18 |
α-synuclein seed amplification and its uses in Parkinson's disease
|
Berg, Daniela
|
|
|
22 |
5 |
p. 369-371
|
article
|
| 19 |
The hyperacute vestibular syndrome: ear or brain?
|
Kaski, Diego
|
|
|
22 |
5 |
p. 377-378
|
article
|
| 20 |
Thrombolysis for acute ischaemic stroke: current status and future perspectives
|
Tsivgoulis, Georgios
|
|
|
22 |
5 |
p. 418-429
|
article
|
| 21 |
Turin as a neuroscience cradle
|
Vercelli, Alessandro
|
|
|
22 |
5 |
p. 381
|
article
|
| 22 |
Vera Bril: what if?
|
Burton, Adrian
|
|
|
22 |
5 |
p. 379
|
article
|
Journal description